CamGene Therapeutics
PrivateLast Round
Seed
Oct 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CamGene Therapeutics is a biotechnology company developing RNA-based therapeutics designed to address the underlying cellular dysfunction that causes hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CamGene Therapeutics Comparables
Compare CamGene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rinri Therapeutics | 79% | |
| Spiral Therapeutics | 76% | |
| Suzhou Otovia Therapeutics Co., Ltd. | 71% |
CamGene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2025 | ||||
| Pre Seed | Apr 5, 2024 |
Key People
Founding team and executive leadership
CamGene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Enterprise Ventures | Seed |
| o2h ventures | Seed, Pre Seed |
| UK Innovation & Science Seed Fund | Seed |
| LongRiver Investments | Seed |
| Eos Advisory | Seed |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 7, 2026
Grew 60% QoQ from 5 to 8 employees.
- Oct 29, 2025
Led by UK Innovation & Science Seed Fund with participation from Eos Advisory, o2h ventures, Parkwalk Advisors, and Cambridge Enterprise Ventures.
CamGene Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CamGene Therapeutics's valuation, stock price, and market status.
Is CamGene Therapeutics a public or private company?
CamGene Therapeutics is a private company.
What is the current stock price of CamGene Therapeutics?
CamGene Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is CamGene Therapeutics worth (valuation)?
Valuation information for CamGene Therapeutics is not publicly available.
Can I buy CamGene Therapeutics stock?
CamGene Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CamGene Therapeutics's last funding round?
CamGene Therapeutics's most recent funding round was Seed on October 29, 2025.
Who are the main investors in CamGene Therapeutics?
Key investors in CamGene Therapeutics include o2h ventures, UK Innovation & Science Seed Fund.
Will CamGene Therapeutics IPO soon?
No public IPO plans have been announced for CamGene Therapeutics.
How can I track CamGene Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CamGene Therapeutics's secondary market activity and sign up for updates.